1284 related articles for article (PubMed ID: 1315257)
1. Responsiveness of the intestinal 1,25-dihydroxyvitamin D3 receptor to magnesium depletion in the rat.
Lemay J; Gascon-Barré M
Endocrinology; 1992 May; 130(5):2767-77. PubMed ID: 1315257
[TBL] [Abstract][Full Text] [Related]
2. Vitamin D depletion retards the normal regeneration process after partial hepatectomy in the rat.
Ethier C; Kestekian R; Beaulieu C; Dubé C; Havrankova J; Gascon-Barré M
Endocrinology; 1990 Jun; 126(6):2947-59. PubMed ID: 2190801
[TBL] [Abstract][Full Text] [Related]
3. Expression of the 1,25-dihydroxyvitamin D3-24-hydroxylase gene in rat intestine: response to calcium, vitamin D3 and calcitriol administration in vivo.
Lemay J; Demers C; Hendy GN; Delvin EE; Gascon-Barré M
J Bone Miner Res; 1995 Aug; 10(8):1148-57. PubMed ID: 8585417
[TBL] [Abstract][Full Text] [Related]
4. Hypocalcemia, regardless of the vitamin D status, decreases epidermal growth factor receptor density and autophosphorylation in rat livers.
Ethier C; Goupil D; Demers C; Hendy GN; Gascon-Barré M
Endocrinology; 1993 Aug; 133(2):780-92. PubMed ID: 8393775
[TBL] [Abstract][Full Text] [Related]
5. Evidence for in vivo upregulation of the intestinal vitamin D receptor during dietary calcium restriction in the rat.
Favus MJ; Mangelsdorf DJ; Tembe V; Coe BJ; Haussler MR
J Clin Invest; 1988 Jul; 82(1):218-24. PubMed ID: 2839546
[TBL] [Abstract][Full Text] [Related]
6. Parathyroid hormone down-regulates 1,25-dihydroxyvitamin D receptors (VDR) and VDR messenger ribonucleic acid in vitro and blocks homologous up-regulation of VDR in vivo.
Reinhardt TA; Horst RL
Endocrinology; 1990 Aug; 127(2):942-8. PubMed ID: 2164926
[TBL] [Abstract][Full Text] [Related]
7. Contrasting effects of exogenous 1,25-dihydroxyvitamin D [1,25-(OH)2D] versus endogenous 1,25-(OH)2D, induced by dietary calcium restriction, on vitamin D receptors.
Goff JP; Reinhardt TA; Beckman MJ; Horst RL
Endocrinology; 1990 Feb; 126(2):1031-5. PubMed ID: 2153516
[TBL] [Abstract][Full Text] [Related]
8. Influence of calcium or 1,25-dihydroxyvitamin D3 supplementation on the hepatic microsomal and in vivo metabolism of vitamin D3 in vitamin D-depleted rats.
Haddad P; Gascon-Barré M; Brault G; Plourde V
J Clin Invest; 1986 Dec; 78(6):1529-37. PubMed ID: 3023446
[TBL] [Abstract][Full Text] [Related]
9. Selective biological response by target organs (intestine, kidney, and bone) to 1,25-dihydroxyvitamin D3 and two analogues.
Norman AW; Sergeev IN; Bishop JE; Okamura WH
Cancer Res; 1993 Sep; 53(17):3935-42. PubMed ID: 8395333
[TBL] [Abstract][Full Text] [Related]
10. Biological activity assessment of 1 alpha,25-dihydroxyvitamin D3-26,23-lactone in the rat.
Ishizuka S; Ishimoto S; Norman AW
J Steroid Biochem; 1984 Feb; 20(2):611-5. PubMed ID: 6323873
[TBL] [Abstract][Full Text] [Related]
11. Apparent nonnuclear regulation of intestinal phosphate transport: effects of 1,25-dihydroxyvitamin D3,24,25-dihydroxyvitamin D3, and 25-hydroxyvitamin D3.
Nemere I
Endocrinology; 1996 Jun; 137(6):2254-61. PubMed ID: 8641173
[TBL] [Abstract][Full Text] [Related]
12. Homologous up-regulation of vitamin D receptors is tissue specific in the rat.
Gensure RC; Antrobus SD; Fox J; Okwueze M; Talton SY; Walters MR
J Bone Miner Res; 1998 Mar; 13(3):454-63. PubMed ID: 9525346
[TBL] [Abstract][Full Text] [Related]
13. Bone mineral homeostasis in spontaneously diabetic BB rats. I. Abnormal vitamin D metabolism and impaired active intestinal calcium absorption.
Nyomba BL; Verhaeghe J; Thomasset M; Lissens W; Bouillon R
Endocrinology; 1989 Feb; 124(2):565-72. PubMed ID: 2536313
[TBL] [Abstract][Full Text] [Related]
14. Plasma Ca influences vitamin D metabolite levels as rats develop vitamin D deficiency.
Kollenkirchen U; Walters MR; Fox J
Am J Physiol; 1991 Mar; 260(3 Pt 1):E447-52. PubMed ID: 1848406
[TBL] [Abstract][Full Text] [Related]
15. Evidence of an age-related decrease in intestinal responsiveness to vitamin D: relationship between serum 1,25-dihydroxyvitamin D3 and intestinal vitamin D receptor concentrations in normal women.
Ebeling PR; Sandgren ME; DiMagno EP; Lane AW; DeLuca HF; Riggs BL
J Clin Endocrinol Metab; 1992 Jul; 75(1):176-82. PubMed ID: 1320048
[TBL] [Abstract][Full Text] [Related]
16. Biological activity assessment of 1 alpha,25-dihydroxyvitamin D3-26,23-lactone and its intermediate metabolites in vivo and in vitro.
Ishizuka S; Sumitani K; Hiura K; Kawata T; Okawa M; Hakeda Y; Kumegawa M
Endocrinology; 1990 Aug; 127(2):695-701. PubMed ID: 2373050
[TBL] [Abstract][Full Text] [Related]
17. The number of 1,25-dihydroxyvitamin D3 receptors is decreased in both intestine and kidney of genetically diabetic db/db mice.
Ishida H; Cunningham NS; Henry HL; Norman AW
Endocrinology; 1988 Jun; 122(6):2436-43. PubMed ID: 2836163
[TBL] [Abstract][Full Text] [Related]
18. Developmental changes in the responsiveness of rat kidney to vitamin D metabolites.
Sömjen D; Weisman Y; Berger E; Earon Y; Kaye AM; Binderman I
Endocrinology; 1986 Jan; 118(1):354-9. PubMed ID: 3000745
[TBL] [Abstract][Full Text] [Related]
19. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
20. 1 beta, 25 (OH)2-vitamin D3 is an antagonist of 1 alpha,25 (OH)2-vitamin D3 stimulated transcaltachia (the rapid hormonal stimulation of intestinal calcium transport).
Norman AW; Nemere I; Muralidharan KR; Okamura WH
Biochem Biophys Res Commun; 1992 Dec; 189(3):1450-6. PubMed ID: 1336368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
